
Peptides function as critical signaling molecules within the human body, categorized by their receptor interactions and biological targets. BPC-157, originally derived from gastric juices, demonstrates potential for accelerating tissue repair and modulating gut-brain signaling, though human clinical data remain limited compared to animal models. Beyond regenerative applications, peptides like EDR (formerly Pinellon) and thymic-derived compounds offer pathways to enhance circadian rhythmicity, immune function, and metabolic health. While GLP-1 agonists have revolutionized weight management and metabolic disease treatment, they carry risks of gastrointestinal distress and potential impacts on dopaminergic signaling. Clinical application of these substances requires careful monitoring, as the current landscape is characterized by varying product quality, regulatory ambiguity, and a reliance on anecdotal evidence over large-scale, randomized human trials.
Sign in to continue reading, translating and more.
Open full episode in Podwise